Xiaozhi Zhang

Xiaozhi Zhang


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
RXRuxing Xi
Ruxing Xi
SPShupei Pan
Shupei Pan
XCXin Chen
Xin Chen
BHBeina Hui
Beina Hui
LZLi Zhang
Li Zhang
SCShaomin Che
Shaomin Che
HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo

15 November 2016 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
YLYi Li
Yi Li
JMJing-Lu Ma
Jing-Lu Ma
XCXin Chen
Xin Chen
FTFeng-Wen Tang
Feng-Wen Tang
XZXiaozhi Zhang
Xiaozhi Zhang
Large tumor motion often leads to larger treatment volumes, especially the lung tumor located in lower lobe and adhered to chest wall or diaphragm. The purpose of this work is to investigate the impacts of planning target volume (PTV) margin on Stereotactic Body Radiotherapy (SBRT) in non-small cell lung cancer (NSCLC). Subjects include 20 patients with the lung tumor located in lower lobe and adhered to chest wall or diaphragm who underwent SBRT. Four-dimensional computed tomography (4DCT) were acquired at simulation to evaluate the tumor intra-fractional centroid and boundary changes, and Cone-beam Computer Tomography (CBCT) were acquired during each treatment to evaluate the tumor inter-fractional set-up displacement. The margin to compensate for tumor variations uncertainties was calculated with various margin calculated recipes published in the exiting literatures. The means (±standard deviation) of tumor centroid changes were 0.16 (±0.13) cm, 0.22 (±0.15) cm, and 1.37 (±0.81) cm in RL, AP, and SI directions, respectively. The means (±standard deviation) of tumor edge changes were 0.21 (±0.18) cm, 0.50 (±0.23) cm, and 0.19 (±0.44) cm in RL, AP, and SI directions, respectively. The means (±standard deviation) of tumor set-up displacement were 0.03 (±0.24) cm, 0.02 (±0.26) cm, and 0.02 (±0.43) cm in RL, AP, and SI directions, respectively. The PTV margin to compensate for lung cancer tumor variations uncertainties were 0.88, 0.98 and 2.68 cm in RL, AP and SI directions, which were maximal among all margin recipes. 4DCT and CBCT imaging are appropriate to account for the tumor intra-fractional centroid, boundary variations and inter-fractional set-up displacement. The PTV margin to compensate for lung cancer tumor variations uncertainties can be obtained. Our results show that a conventional 1.0 cm margin in the SI plane dose not suffice to compensate the geometrical variety of the tumor located in lower lobe and adhered to chest wall and diaphragm.

14 August 2020 in Medicine
Verified
Journal Article
Open access
HGHongxiang Gao
Hongxiang Gao
YDYazheng Dang
Yazheng Dang
TQTao Qi
Tao Qi
SHShigao Huang
Shigao Huang
XZXiaozhi Zhang
Xiaozhi Zhang
This study is to establish the nomogram model and provide clinical therapy decision-making for extensive-stage small-cell lung cancer (ES-SCLC) patients with different metastatic sites using the Surveillance, Epidemiology, and End Results (SEER) Program. A total of 10,025 patients of ES-SCLC with metastasis from January 2010 to December 2016 were enrolled from the SEER database. All samples were randomly divided into a derivation cohort and a validation cohort, and the derivation cohort was divided into 6 groups by different metastatic sites: bone, liver, lung, brain, multiple organs, and other organs. Using Cox proportional hazards models to analyze candidate prognostic factors, screening out the independent prognostic factors to establish the nomogram. Compare the different models by Net reclassification improvement and integrated discrimination improvement. Concordance index (C-index) and the calibration curve were used to verify the prediction efficiency of the nomogram in the derivation cohort and validation cohort. In the derivation cohort, the median overall survival was 7 months. The overall survival rates at 6-month, 1-year, and 2-year were 55.07%, 24.61%, and 7.56%, respectively. The median survival time was 10, 8, 7, 9, 7, and 6 months for the 6 groups of different metastatic sites: other, bone, liver, lung, brain, and multiple organs, respectively. Age, sex, race, T, N, distant metastatic site, and chemotherapy were contained in the final nomogram prognostic model. The C-index was 0.6569777 in the derivation cohort and 0.8386301 in the validation cohort. The survival time of ES-SCLC patients with different metastatic sites was significantly different. The nomogram can effectively predict the prognosis of individuals and provide a basis for clinical decision-making.

15 July 2025 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
HYHaihua Yang
Haihua Yang
KCKuifei Chen
Kuifei Chen
YMYinan Meng
Yinan Meng
ZCZiran Chen
Ziran Chen
YXYixiu Xu
Yixiu Xu
XZXiaozhi Zhang
Xiaozhi Zhang
The tumor microenvironment (TME) is a diverse and intricate structure consisting of tumor cells, stromal cells, endothelial cells, and immune cells. It is characterized by the communication between tumor cells and both innate and adaptive immune cells. Tertiary lymphoid structures (TLS) are temporary abnormal collections of lymphoid tissues in which specialized immune responses against tumors can occur. B cells are crucial for the prognostic prediction of various cancers, particularly in response to immunotherapy. There are many types of B cells within the TME, including naive, terminally differentiated plasma, and memory B cells. Our focus was to understand the various types of B cells and how radiation therapy influences B cells in TLS. In this review, we discuss the notion that radiotherapy may alter the creation and function of B cells in TLS, which could result in a powerful and advanced form of cancer immunity.

2 August 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
YLYi Li
Yi Li
WWWenjing Wu
Wenjing Wu
YSYuchen Sun
Yuchen Sun
DYDequan Yu
Dequan Yu
YZYuemei Zhang
Yuemei Zhang
YLYongkai Lu
Yongkai Lu
Purpose: Our purpose was to investigate the influence of atlas library size and CT cross-slice number on the accuracy and efficiency of the atlas-based auto-segmentation (ABAS) method for the automatic contouring of clinical treatment volume (CTV) and organs at risk (OARs) during cervical cancer radiotherapy.Methods: Of 140 cervical cancer patients, contours from 20, 40, 60, 80, 100, and 120 patients were selected incrementally to create six atlas library groups in ABAS. Another 20 tested patients were automatically contoured with the ABAS method and manually contoured by the same professional oncologist. Contours included CTV, bladder, rectum, femoral head-L, femoral head-R, and spinal cord. The CT cross-slice numbers of the 20 tested patients included 61, 65, 72, 75, 81, and 84. The index of dice similarity coefficients (DSCs) and Hausdorff distance (HD) were used to assess the consistency between ABAS automatic contouring and manual contouring. The randomized block analysis of variance and paired t-test were used for statistical analysis.Results: The mean DSC values of “CTV, bladder, femoral head, and spinal cord” were all larger than 0.8. The femoral head and spinal cord showed a high degree of agreement between ABAS automatic contouring and manual contouring, with a mean DC >0.80 and HD <1 cm in all atlas library groups. A post-hoc least significant difference comparison indicated that no significant difference had been found between different atlas library sizes with DSC and HD values. For ABAS efficiency, the atlas library size had no effect on the time of ABAS automatic contouring. The time of automatic contouring increased slightly with the increase in CT cross-slice numbers, which were 99.9, 106.8, 114.0, 120.6, 127.9, and 134.8 s with CT cross-slices of 61, 65, 72, 75, 81, and 84, respectively.Conclusion: A total of 20 atlas library sizes and a minimum CT cross-slice number including CTV and OARs are enough for ensuring the accuracy and efficiency of ABAS automatic contouring during cervical cancer radiotherapy.

7 October 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YLYi Li
Yi Li
WWWenjing Wu
Wenjing Wu
RHRuixin He
Ruixin He
YLYongkai Lu
Yongkai Lu
YZYuemei Zhang
Yuemei Zhang
XZXiaozhi Zhang
Xiaozhi Zhang
Inter-fractional tumor variance would lead to insufficient dosage or overdose in tumor region during lung cancer radiotherapy. However, previous works have not considered influence of inter-fractional tumor amplitude variance at treatment position due to lack of effective evaluation method during radiotherapy, especially for lung tumor within the lower lobe. Our objective was to investigate inter-fractional tumor baseline shift and amplitude variance due to respiratory motion with 4DCBCT simulation and guidance during stereotactic ablative body radiotherapy (SABR) for lung tumor. Subject included 19 patients with lung tumor within the lower lobe. 4DCBCT-simulated images at treatment position were acquired sequentially to determine internal tumor volume (ITV) and reference tumor motion at simulation process. Compared with reference tumor motion, 95 4DCBCT-guided images were acquired during each treatment to evaluate inter-fractional tumor baseline shift and amplitude variance, which were − 0.0 ± 1.3 mm and − 0.2 ± 1.4 mm in left–right(LR) direction, 0.9 ± 2.3 mm and 0.4 ± 2.9 mm in superior-inferior (SI) direction, 0.1 ± 1.5 mm and − 0.4 ± 2.0 mm in anterior–posterior (AP) direction. ITV margin were 3.5 mm, 7.5 mm and 5.3 mm in LR, SI and AP directions with van Herk’s (Int J Radiat Oncol Biol Phys 52(5):1407–1422, 2002) formula. 4DCBCT simulation and guidance is a reliable method to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe. ITV margin of 3.5 mm, 7.5 mm and 5.3 mm in LR, SI and AP directions would ensure greater tumor coverage during SABR for lung tumor within the lower lobe.